Emerging Markets Growth Fund, Inc. Class R-6 (REFGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
7.62
+0.02 (0.26%)
Jun 5, 2025, 4:00 PM EDT
14.59% (1Y)
Fund Assets | 2.30B |
Expense Ratio | 0.73% |
Min. Investment | $250 |
Turnover | n/a |
Dividend (ttm) | 0.10 |
Dividend Yield | 1.33% |
Dividend Growth | 4.11% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 23, 2024 |
Previous Close | 7.60 |
YTD Return | 13.39% |
1-Year Return | 14.59% |
5-Year Return | 23.18% |
52-Week Low | 6.25 |
52-Week High | 7.62 |
Beta (5Y) | n/a |
Holdings | 141 |
Inception Date | Sep 1, 2017 |
About REFGX
The Emerging Markets Growth Fund, Inc. Class R-6 (REFGX) seeks to provide holders of the Fund's common shares with a high level of current income exempt from federal income tax, consistent with preservation of capital.
Category Diversified Emerging Mkts
Performance Rating Below Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol REFGX
Share Class Class R-6
Index MSCI Emerging Markets IMI NR USD
Performance
REFGX had a total return of 14.59% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.23%.
Top 10 Holdings
30.98% of assetsName | Symbol | Weight |
---|---|---|
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 2330 | 8.29% |
TENCENT HOLDINGS LTD | 0700 | 5.18% |
CAPITAL GROUP CENTRAL CASH FUND | CMQXX | 3.04% |
Kimberly-Clark Corporation | KMB | 2.38% |
NETEASE INC | 9999 | 2.21% |
SHENZHEN INOVANCE TECHNOLOGY CO LTD A (SZSE NORTH) | 300124 | 2.18% |
INNOVENT BIOLOGICS INC | 1801 | 2.12% |
MEITUAN CL B | 3690 | 1.97% |
PING AN INSURANCE GROUP CO OF CHINA LTD CL H | 2318 | 1.82% |
BeOne Medicines Ltd. | ONC | 1.79% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 23, 2024 | $0.1013 | Dec 24, 2024 |
Dec 21, 2023 | $0.0973 | Dec 22, 2023 |
Dec 22, 2022 | $0.0813 | Dec 23, 2022 |
Dec 22, 2021 | $0.9443 | Dec 23, 2021 |
Dec 22, 2020 | $0.5392 | Dec 23, 2020 |
Dec 26, 2019 | $0.4847 | Dec 27, 2019 |